年轻女性乳腺癌危险因素及风险预测模型构建
Risk Factors of Breast Cancer in Young Women and Construction of Risk Prediction Model
DOI: 10.12677/acm.2025.1551631, PDF,   
作者: 姜 萌*, 戚新雨, 柯明星, 丁剑鸣#:义乌市妇幼保健院放射科,浙江 金华;王思成:浦江县中医院针灸推拿科,浙江 金华
关键词: 年轻乳腺癌危险因素预测模型Young Breast Cancer Risk Factors Prediction Model
摘要: 目的:根据收住乳腺外科年轻女性(<40岁)患者的临床及影像资料评估其危险因素,并构建风险预测模型以期更早期、更准确地预测年轻乳腺癌的发生。方法:收集2020年1月~2024年12月收住乳腺外科的211例年轻女性患者的临床和影像资料,根据病理结果分为年轻乳腺癌组(n = 85)和年轻非乳腺癌组(n = 126)。采用单因素分析和二元Logistic回归分析,探讨年轻乳腺癌患者的相关危险因素并构建风险预测模型,绘制ROC曲线,并计算该模型的灵敏度和特异性,利用Bootstrap重复抽样法对该预测模型的准确性进行内部验证,判断该预测模型的可靠性。结果:单因素分析显示NLR、LMR、钙化特点、淋巴结状态、边缘、纤维蛋白原、睾酮、促黄体生成素均有统计学意义(P < 0.05)。二元Logistic回归分析显示NLR、LMR、钙化特点、淋巴结状态、边缘、促黄体生成素是年轻乳腺癌的独立危险因素(均P < 0.05)。此风险预测模型AUC为0.991 (P < 0.001),特异性为0.968,敏感性为0.976。内部验证校正后C-index指数为0.982。结论:此风险预测模型能较精准地预测年轻乳腺癌是否发生。
Abstract: Objective: To evaluate the risk factors of young female patients (under 40 years old) admitted to the breast surgery department based on their clinical and imaging data, and to construct a risk prediction model in order to predict the occurrence of young breast cancer earlier and more accurately. Methods: Clinical and imaging data of 211 young female patients admitted to the breast surgery department from January 2020 to December 2024 were collected. These patients were divided into the young breast cancer group (n = 85) and the young non-breast cancer group (n = 126) according to the pathological results. Univariate analysis and binary Logistic regression analysis were used to explore the related risk factors of young breast cancer patients and construct a risk prediction model. ROC curves were drawn, and the sensitivity and specificity of the model were calculated. The accuracy of this prediction model was internally validated using the Bootstrap repeated sampling method, and the reliability of the prediction model was judged. Results: Univariate analysis showed that NLR, LMR, calcification characteristics, lymph node status, margin, fibrinogen, testosterone, and luteinizing hormone were statistically significant (all P < 0.05). Binary Logistic regression analysis showed that NLR, LMR, calcification characteristics, lymph node status, margin, and luteinizing hormone were independent risk factors for young breast cancer (all P < 0.05). The AUC of this risk prediction model was 0.991 (P < 0.001), with a specificity of 0.968 and a sensitivity of 0.976. The corrected C-index of internal validation was 0.982. Conclusion: This risk prediction model can accurately predict whether young breast cancer will occur.
文章引用:姜萌, 王思成, 戚新雨, 柯明星, 丁剑鸣. 年轻女性乳腺癌危险因素及风险预测模型构建[J]. 临床医学进展, 2025, 15(5): 2393-2401. https://doi.org/10.12677/acm.2025.1551631

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30. [Google Scholar] [CrossRef] [PubMed]
[3] Zhang, W., Zhang, B., He, J., Fan, J., Li, J., Zhang, B., et al. (2021) Clinicopathological Characteristics and Treatment of Young Women with Breast Cancer in China: A Nationwide Multicenter 10-Year Retrospective Study. Gland Surgery, 10, 175-185. [Google Scholar] [CrossRef] [PubMed]
[4] Li, J., Zhang, B., Fan, J., Pang, Y., Zhang, P., Wang, S., et al. (2011) A Nation-Wide Multicenter 10-Year (1999-2008) Retrospective Clinical Epidemiological Study of Female Breast Cancer in China. BMC Cancer, 11, Article No. 364. [Google Scholar] [CrossRef] [PubMed]
[5] Desiris, K., Dragoumis, D., Assimaki, A. and Tsiftsoglou, A. (2012) 51 Very Young Women (<35 Years) with Primary Breast Cancer. A Single Institution Retrospective Analysis (2005-2009). European Journal of Cancer, 48, S55. [Google Scholar] [CrossRef
[6] Han, J., Jiang, Y., Zhang, C., Pang, D., Zhang, M., Wang, Y., et al. (2011) Clinicopathologic Characteristics and Prognosis of Young Patients with Breast Cancer. The Breast, 20, 370-372. [Google Scholar] [CrossRef] [PubMed]
[7] Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., et al. (2002) Very Young Women (<35 Years) with Operable Breast Cancer: Features of Disease at Presentation. Annals of Oncology, 13, 273-279. [Google Scholar] [CrossRef] [PubMed]
[8] El Saghir, N.S., Seoud, M., Khalil, M.K., Charafeddine, M., Salem, Z.K., Geara, F.B., et al. (2006) Effects of Young Age at Presentation on Survival in Breast Cancer. BMC Cancer, 6, Article No. 194. [Google Scholar] [CrossRef] [PubMed]
[9] Dubsky, P.C., Gnant, M.F.X., Taucher, S., Roka, S., Kandioler, D., Pichler-Gebhard, B., et al. (2002) Young Age as an Independent Adverse Prognostic Factor in Premenopausal Patients with Breast Cancer. Clinical Breast Cancer, 3, 65-72. [Google Scholar] [CrossRef] [PubMed]
[10] 邬昊, 吕青. 全球及中国乳腺癌的流行病学趋势及防控启示: 2018-2022年《全球癌症统计报告》解读[J]. 中国普外基础与临床杂志, 2024, 31(7): 796-802.
[11] Agarwal, G., Pradeep, P.V., Aggarwal, V., Yip, C. and Cheung, P.S.Y. (2007) Spectrum of Breast Cancer in Asian Women. World Journal of Surgery, 31, 1031-1040. [Google Scholar] [CrossRef] [PubMed]
[12] Kim, E., Noh, W.C., Han, W. and Noh, D. (2011) Prognostic Significance of Young Age (<35 Years) by Subtype Based on ER, PR, and HER2 Status in Breast Cancer: A Nationwide Registry‐Based Study. World Journal of Surgery, 35, 1244-1253. [Google Scholar] [CrossRef] [PubMed]
[13] Han, W., Kim, S.W., Ae Park, I., Kang, D., Kim, S., Youn, Y., et al. (2004) Young Age: An Independent Risk Factor for Disease-Free Survival in Women with Operable Breast Cancer. BMC Cancer, 4, Article No. 82. [Google Scholar] [CrossRef] [PubMed]
[14] Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., et al. (2018) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. [Google Scholar] [CrossRef] [PubMed]
[15] Sopik, V. (2020) International Variation in Breast Cancer Incidence and Mortality in Young Women. Breast Cancer Research and Treatment, 186, 497-507. [Google Scholar] [CrossRef] [PubMed]
[16] Daly, A.A., Rolph, R., Cutress, R.I. and Copson, E.R. (2021) A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer. Breast Cancer: Targets and Therapy, 13, 241-257. [Google Scholar] [CrossRef] [PubMed]
[17] Johnson, R.H., Anders, C.K., Litton, J.K., Ruddy, K.J. and Bleyer, A. (2018) Breast Cancer in Adolescents and Young Adults. Pediatric Blood & Cancer, 65, e27397. [Google Scholar] [CrossRef] [PubMed]
[18] Paluch-Shimon, S., Cardoso, F., Partridge, A.H., Abulkhair, O., Azim, H.A., Bianchi-Micheli, G., et al. (2020) ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4). Annals of Oncology, 31, 674-696. [Google Scholar] [CrossRef] [PubMed]
[19] 叶丹, 李勇, 林琅, 等. 年轻乳腺癌诊断延迟影响因素及现状[J]. 现代医药卫生, 2022, 38(9): 1540-1543.
[20] 赵津, 杨子佳. 年轻不是乳腺肿瘤“挡箭牌” [N].天津日报, 2024-12-24(011).
[21] 魏冬, 温静, 曾蓓蕾, 等. 炎症标志物与T1期乳腺癌预后因素分析及预测模型构建[J]. 四川医学, 2024, 45(2): 155-162.
[22] 汤婵丽, 李英, 章小飞. 术前中性粒细胞与淋巴细胞计数比值联合糖类抗原153对乳腺癌的诊断价值[J]. 中国妇幼保健, 2023, 38(2): 237-240.
[23] 程晓成, 卫翀羿, 柴效科, 等. 术前外周血红细胞分布宽度联合中性粒细胞/淋巴细胞比值在乳腺癌诊断中的临床价值[J]. 中国现代普通外科进展, 2023, 26(9): 703-708.
[24] 于艳艳, 张丽媛, 孟洁. 外周血NLR、PLR和SII对乳腺肿瘤的诊断价值[J]. 滨州医学院学报, 2024, 47(5): 430-432.
[25] 徐恩松, 左燕雨, 李英霞, 等. 外周血NLR、PLR、SII对进展期NSCLC患者化疗疗效的预测价值[J]. 实用癌症杂志, 2025, 40(3): 369-372.
[26] 谢兰兰, 李进, 朱奕, 等. 中性粒细胞/淋巴细胞比值与预后营养指数早期预测直肠癌术后吻合口漏的价值[J]. 腹腔镜外科杂志, 2022, 27(10): 758-762.
[27] 滕玥玥, 黄妙君, 黄胜超, 等. NLR、PLR、SII、LMR、CRP在乳腺癌患者血清中表达意义的研究进展[J]. 广东医科大学学报, 2024, 42(2): 203-208.
[28] 王坤英, 张蓬杰, 苏兵, 等. 乳腺癌患者血常规及PLR、NLR、LMR特征分析[J]. 检验医学与临床, 2022, 19(1): 84-89.
[29] 徐维琳, 周树, 唐金海, 等. 淋巴细胞/单核细胞比值在乳腺癌新辅助化疗疗效评估中的预测价值研究[J]. 中国肿瘤外科杂志, 2023, 15(1): 1-6.
[30] Ni, X., Zhang, X., Ou-Yang, Q., Qian, G., Wang, L., Chen, S., et al. (2014) An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy. PLOS ONE, 9, e111886. [Google Scholar] [CrossRef] [PubMed]
[31] 王锋, 陈体, 刘金岭. MR影像组学相关指标与超声定量参数对乳腺癌患者NACT疗效的预测价值[J]. 实用癌症杂志, 2024, 39(11): 1811-1814.
[32] Guo, Q., Dong, Z., Zhang, L., Ning, C., Li, Z., Wang, D., et al. (2017) Ultrasound Features of Breast Cancer for Predicting Axillary Lymph Node Metastasis. Journal of Ultrasound in Medicine, 37, 1354-1353. [Google Scholar] [CrossRef] [PubMed]
[33] Lee, J.J., Jung, Y.L., Cheong, T., Espejo Valle-Inclan, J., Chu, C., Gulhan, D.C., et al. (2023) Erα-Associated Translocations Underlie Oncogene Amplifications in Breast Cancer. Nature, 618, 1024-1032. [Google Scholar] [CrossRef] [PubMed]
[34] Schally, A.V., Block, N.L. and Rick, F.G. (2017) Discovery of LHRH and Development of LHRH Analogs for Prostate Cancer Treatment. The Prostate, 77, 1036-1054. [Google Scholar] [CrossRef] [PubMed]
[35] Hackshaw, A. (2009) Luteinizing Hormone-Releasing Hormone (LHRH) Agonists in the Treatment of Breast Cancer. Expert Opinion on Pharmacotherapy, 10, 2633-2639. [Google Scholar] [CrossRef] [PubMed]